ID   SR-1
AC   CVCL_J389
DR   Wikidata; Q54955624
RX   PubMed=15381372;
CC   Population: Korean.
CC   Doubling time: ~24 hours (PubMed=15381372).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
RX   PubMed=15381372; DOI=10.1016/j.cancergencyto.2004.01.009;
RA   Kwon H.-C., Kim S.-H., Kim J.-S., Han H., Roh M.S., Han J.-Y.,
RA   Seo S.-Y., Lee Y.-H., Kim H.-J.;
RT   "Establishment and characterization of an STI571-resistant human
RT   myelogenous leukemia cell line, SR-1.";
RL   Cancer Genet. Cytogenet. 154:52-56(2004).
//